Literature DB >> 21176229

Involving users in the design of a randomised controlled trial of an intervention to promote early presentation in breast cancer: qualitative study.

Lindsay J L Forbes1, Carol McNaughton Nicholls, Louise Linsell, Jenny Graham, Charlotte Tompkins, Amanda J Ramirez.   

Abstract

BACKGROUND: The purpose of this study was to explore women's views of the design of a large pragmatic cost-effectiveness randomised controlled trial of the policy of offering a health professional-delivered intervention to promote early presentation with breast symptoms in older women and thereby improve survival, with a view to informing protocol development. The trial will recruit over 100,000 healthy women aged 67+, and outcome data will be collected on those who develop breast cancer. The scale of the trial and the need for long-term follow-up presented a number of design challenges in relation to obtaining consent, ascertaining and contacting participants who developed breast cancer, and collecting outcome data.
METHODS: Qualitative study involving 69 women participating in 7 focus groups and 17 in-depth interviews. 15 women had a previous diagnosis of breast cancer and 54 did not.
RESULTS: The women held strong views and had a good understanding of the rationale of the design of clinical trials. The women recognised that in a very large trial with long-term follow-up it was necessary to incorporate design features to make the trial feasible and efficient. Most strikingly, they supported the idea of opt-out consent and identifying women with breast cancer using routine datasets.
CONCLUSIONS: This model of user involvement engaged women well with the design challenges of the trial and led to improvements to the protocol. The study strengthens the case for user involvement, in particular through focus groups and in-depth interviews, in the design of trials.

Entities:  

Mesh:

Year:  2010        PMID: 21176229      PMCID: PMC3023725          DOI: 10.1186/1471-2288-10-110

Source DB:  PubMed          Journal:  BMC Med Res Methodol        ISSN: 1471-2288            Impact factor:   4.615


  18 in total

Review 1.  Influence of delay on survival in patients with breast cancer: a systematic review.

Authors:  M A Richards; A M Westcombe; S B Love; P Littlejohns; A J Ramirez
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

2.  Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial.

Authors:  J H Scholefield; S Moss; F Sufi; C M Mangham; J D Hardcastle
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

Review 3.  Ethical issues in the design and conduct of cluster randomised controlled trials.

Authors:  S J Edwards; D A Braunholtz; R J Lilford; A J Stevens
Journal:  BMJ       Date:  1999-05-22

4.  Recruiting patients to medical research: double blind randomised trial of "opt-in" versus "opt-out" strategies.

Authors:  Cornelia Junghans; Gene Feder; Harry Hemingway; Adam Timmis; Melvyn Jones
Journal:  BMJ       Date:  2005-09-12

5.  National survey of British public's views on use of identifiable medical data by the National Cancer Registry.

Authors:  Geraldine Barrett; Jackie A Cassell; Janet L Peacock; Michel P Coleman
Journal:  BMJ       Date:  2006-04-28

6.  Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care.

Authors:  Sandra M Eldridge; Deborah Ashby; Gene S Feder
Journal:  Clin Trials       Date:  2005       Impact factor: 2.486

7.  What do I want from health research and researchers when I am a patient?

Authors:  I Chalmers
Journal:  BMJ       Date:  1995-05-20

8.  Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Authors:  E J Robinson; C E P Kerr; A J Stevens; R J Lilford; D A Braunholtz; S J Edwards; S R Beck; M G Rowley
Journal:  Health Technol Assess       Date:  2005-03       Impact factor: 4.014

9.  What patients want: consumer involvement in the design of a randomized controlled trial of routine oxygen supplementation after acute stroke.

Authors:  Khalid Ali; Christine Roffe; Peter Crome
Journal:  Stroke       Date:  2006-02-02       Impact factor: 7.914

10.  Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial.

Authors:  Liedeke Koops; Richard I Lindley
Journal:  BMJ       Date:  2002-08-24
View more
  7 in total

Review 1.  Applying a community-based participatory research framework to patient and family engagement in the development of patient-centered outcomes research and practice.

Authors:  Simona C Kwon; Shiv Darius Tandon; Nadia Islam; Lindsey Riley; Chau Trinh-Shevrin
Journal:  Transl Behav Med       Date:  2018-09-08       Impact factor: 3.046

2.  Consumer involvement in cancer research: example from a Cancer Network.

Authors:  Mubashir Arain; Sarah Pyne; Nigel Thornton; Susan Palmer; Ricky A Sharma
Journal:  Health Expect       Date:  2013-10-14       Impact factor: 3.377

3.  Using qualitative methods in pilot and feasibility trials to inform recruitment and retention processes in full-scale randomised trials: a qualitative evidence synthesis.

Authors:  Adel Elfeky; Shaun Treweek; Karin Hannes; Hanne Bruhn; Cynthia Fraser; Katie Gillies
Journal:  BMJ Open       Date:  2022-04-18       Impact factor: 3.006

4.  Active patient participation in the development of an online intervention.

Authors:  Inge Renske van Bruinessen; Evelyn M van Weel-Baumgarten; Harm Wouter Snippe; Hans Gouw; Josée M Zijlstra; Sandra van Dulmen
Journal:  JMIR Res Protoc       Date:  2014-11-06

5.  A co-produced method to involve service users in research: the SUCCESS model.

Authors:  Bridie Angela Evans; Alison Porter; Helen Snooks; Vanessa Burholt
Journal:  BMC Med Res Methodol       Date:  2019-02-15       Impact factor: 4.615

6.  Changing Author Guidelines to Include Patient and Public Involvement.

Authors:  Ann Blair Kennedy
Journal:  Int J Ther Massage Bodywork       Date:  2019-06-01

7.  Patient and public involvement in the early stages of clinical trial development: a systematic cohort investigation.

Authors:  Carrol Gamble; Louise Dudley; Alison Allam; Philip Bell; Heather Goodare; Bec Hanley; Jennifer Preston; Alison Walker; Paula Williamson; Bridget Young
Journal:  BMJ Open       Date:  2014-07-23       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.